pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CATALENT · news · pharmadog
← back to CATALENT
News mentioning CATALENT
11
stories
2d
Sionna says good-bye to 46% of staffers, including exec
biospace
5d
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
5d
Scholar Rock secures first FDA approval for muscle-targeting rare disease drug
biospace
22d
Multispecifics are transforming the CDMO development architecture
biospace
Aug 11, 26
Scholar Rock rejigs approval filing after FDA flags violations at Novo plant
biospace
Aug 10, 26
Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
fiercebiotech
Aug 4, 26
Lisata lays off 72% of staffers, sues Kuva after planned merger falls apart
fiercebiotech
Jul 29, 26
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy
biospace
Jul 9, 26
Catalent to divest UK site; Rottendorf, Evonik announce manufacturing builds
endpoints
Jun 4, 26
Mammalian hair, roof leaks: Novo Nordisk's site in Indiana under FDA scrutiny once again
endpoints
May 1, 26
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive
